U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Sri Lankans are voting in a parliamentary election that's key for their new, Marxist-leaning president to consolidate his ...

Right now, Viking does not have any treatments that are formally approved by the FDA. Nevertheless, the company's lead obesity candidate, VK2735, has garnered a lot of attention and is widely ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.